June 2020: There has been a change to the construction of this indicator. Please see the 'Notes and definitions' tab and the Specification for further information. This revised indicator is being published as an experimental statistic. Experimental statistics are official statistics which are published in order to involve users and stakeholders in their development and as a means to build in quality at an early stage.
The percentage of new cases of cancer which were diagnosed at stage 1 or 2 for the specific cancer sites, morphologies and behaviour: Oesophagus; Stomach; Colon; Rectum; Pancreas; Lung; Melanoma of skin; Breast; Cervix; Uterus; Ovary; Prostate; Testis; Kidney; Bladder; Hodgkin lymphoma; Thyroid; Larynx; Oropharynx; Oral cavity; Non-Hodgkin lymphoma.
This indicator relates to a subset of the cancers covered by CCG indicator 1.17 Record of stage of cancer at diagnosis.
Legacy unique identifier: P01817